Regeneron Hits Rival With Patent Suit Over Eye Med Generic
By Kelly Lienhard · November 9, 2023, 5:48 PM EST
Regeneron accused a South Korea-based rival of infringing a slew of patents covering the American biotech company's top eye medication in a new lawsuit filed in West Virginia, claiming that its...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login